DATE: June 3, 2021
TIME: 09:30am IST/12:00pm SGT/01:00pm JST, KST/03:00pm AEST/ 05:00pm NZST
This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy development. The virtual event will feature a series of presentations, followed by Q&A session, from our team of regional technical expert in 4 different languages (English, Japanese, Korean and Chinese).
Jacqueline Ng - Senior Business Development Manager , APJ (Cell & Gene Therapy), Thermo Fisher Scientific
Nobuo Ogita - Business Development Manager , APJ (Cell & Gene Therapy), Thermo Fisher Scientific
Kim Dohyung - Technical Sales Specialist , Korea (Cell Biology) Thermo Fisher Scientific
Jasmin Tseng - Technical Sales Specialist , Taiwan (Cell Biology), Thermo Fisher Scientific
In this webinar, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effective manufacturing. We will highlight the Gibco CTS Rotea Counterflow Centrifugation System, a revolutionary benchtop, closed system which offers exceptional flexibility for cell washing, concentration, and separation by size, with high cell recovery and throughput rate. We will discuss a broad range of cell processing applications (cell isolation, cell separation by size, small to medium-scale processing, cryopreserved cell wash and media exchange, formulation for cryopreservation, RBC lysis or depletion, viral vector clarification) across a variety of cell types (T cells, NK cells, MSCs, HEK293, iPSC spheroids, PBMC and more). The compact footprint, process flexibility, and sterile single-use kit allow the system to seamlessly scale with your process, from research through clinical manufacturing.
Also learn more about how ViaCyte, a clinical stage regenerative medicine company, is focused on delivering novel stem cell-derived pancreatic cell replacement therapies as a functional cure for diabetes. Producing the stem cells required to support development of these therapies and future commercial demand requires an aggressive scale-up effort. As part of this effort, stem cell aggregation, expansion and differentiation processes are being adapted to suspension bioreactor culture. The Gibco CTS Rotea Counterflow Centrifugation System is currently being optimized to integrate with these bioreactors to form a closed, scalable environment for aggregate collection and media exchange. Join us as ViaCyte details how they used the Rotea system to preserve aggregate integrity, morphology, viability, and recovery after processing, and have successfully processed repeated batch feeds on a 3L bioreactor system.
Learning Objectives:
For Research Use Only. Not for use in diagnostic procedures. 2021 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified
Webinars will be available for unlimited on-demand viewing after live event.